[{"id":"6a3c0c51-ec69-425d-bb50-4891cf3084e3","acronym":"","url":"https://clinicaltrials.gov/study/NCT01876212","created_at":"2021-01-18T08:24:44.121Z","updated_at":"2024-07-02T16:36:56.634Z","phase":"Phase 2","brief_title":"Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma","source_id_and_acronym":"NCT01876212","lead_sponsor":"Walter J. Storkus","biomarkers":" CD8 • CXCL10","pipe":" | ","alterations":" M-MDSCs","tags":["CD8 • CXCL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e M-MDSCs"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dasatinib"],"overall_status":"Completed","enrollment":" Enrollment 15","initiation":"Initiation: 05/16/2014","start_date":" 05/16/2014","primary_txt":" Primary completion: 07/11/2018","primary_completion_date":" 07/11/2018","study_txt":" Completion: 07/31/2019","study_completion_date":" 07/31/2019","last_update_posted":"2019-08-22"},{"id":"a2867969-e1e7-49b1-b317-607dc3c5c300","acronym":"","url":"https://clinicaltrials.gov/study/NCT03214718","created_at":"2021-01-18T15:51:49.866Z","updated_at":"2024-07-02T16:37:20.072Z","phase":"","brief_title":"Myeloid Derived Suppressor Cells and Chronic Myeloid Leukemia","source_id_and_acronym":"NCT03214718","lead_sponsor":"Assiut University","biomarkers":" ABL1 • BCR • CD33 • CD14 • ITGAM","pipe":" | ","alterations":" M-MDSCs","tags":["ABL1 • BCR • CD33 • CD14 • ITGAM"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e M-MDSCs"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e imatinib • nilotinib"],"overall_status":"Unknown status","enrollment":" Enrollment 50","initiation":"Initiation: 08/05/2017","start_date":" 08/05/2017","primary_txt":" Primary completion: 08/05/2019","primary_completion_date":" 08/05/2019","study_txt":" Completion: 08/05/2019","study_completion_date":" 08/05/2019","last_update_posted":"2017-07-11"}]